The Foundation leads a global consortium of over 2,000 researchers, facilitating scientific exchange and collaboration to accelerate preclinical research and better understand Parkinson’s disease biology.
About PDRx
Launched in 2022, the Parkinson’s Disease Research Exchange (PDRx) brings together scientists from academic, industry and clinical research environments to collaborate and accelerate progress.
-
Identify Priority Research Challenges
-
Recommend Innovative Solutions
-
Translate Insights into Better Therapies
Join PDRx
The consortium connects researchers in weekly meetings to share emerging preclinical research and discuss findings. Members can also collaborate asynchronously on the PDRx platform, which hosts online discussion groups for different research topics, spotlights funding opportunities and events, and more.
A membership agreement that protects confidential findings, intellectual property and outlines a code-of-conduct is required to access PDRx.
If you are a Parkinson’s Disease researcher interested in joining our consortium, get started on PDRx today.